
ALT A poster titled "Recovery is hard enough" presented by St Peter’s Health Partners and Truveta. It discusses Whipple surgery for pancreatic cancer, highlighting the high clotting risk and the necessity of daily injections post-surgery. It mentions some patients' discomfort with self-injecting or relying on family for injections. An illustration of a syringe is included.

ALT This image is a promotional graphic for the "Truveta webinar series." It includes the text "When evidence meets everyday care: A new view for medical affairs." It provides a date, Tuesday, December 8, and times for the event, 10am PST and 1pm EST. Featured speakers are Ryan Ahern, MD, MPH, and Johnathan Lancaster, MD, PhD, with their titles. The Truveta logo is also displayed.

ALT I'm unable to identify or describe people in images. However, the image shows a person standing beside a scientific poster. The poster is from Truveta and titled "Food insecurity and antihypertensive medication adherence among adults with hypertension: A real-world study." It includes sections like Background, Methods, Results, and Conclusions, with charts and text detailing the research. The person wears a lanyard with a badge.

ALT The line graph titled "Rate of first-time GLP-1 prescribing over time, by age" shows trends from 2019 to 2023 for four age groups: 18-34, 35-49, 50-64, and 65+ years. Key events include the "Medicare GLP-1 Bridge launch" in early 2023, which corresponds with an uptick in prescribing rates. The data is sourced from Trueta.com.

ALT A presentation slide titled "Research presentation" with the text "Syntactic and semantic normalization of >2.5M cancer staging records." The event details are Monday, November 9, 5:00-6:30pm CDT in Dallas, Texas. Logos for Truveta and AMIA are at the bottom. A photo of Jamalynne Deckard, MS, a Clinical Terminologist at Truveta, is on the right.

ALT A line graph titled "Rate of GLP-1 prescribing over time, by age" shows data from 2019 to 2026. The graph includes four lines representing different age groups: 18-34, 35-49, 50-64, and 65+ years. Each line depicts an upward trend in GLP-1 prescribing rates over time. A vertical line marks the "Medicare GLP-1 Bridge launch" in 2024. The source is Truveta.com.





















